Ascendis Pharma A (ASND) FCF Margin Growth (3y) (2017 - 2026)
Ascendis Pharma A (ASND) FCF Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 15,064.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn | 43,141.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,141.00 |
| Dec 31, 2025 | 57,233.00 |
| Sep 30, 2025 | 62,671.00 |
| Jun 30, 2025 | 195,423.00 |
| Mar 31, 2025 | 184,537.00 |
| Dec 31, 2024 | 16,685.00 |
| Sep 30, 2024 | 765,029.00 |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 16,796.00 |
| Sep 30, 2023 | 166,288.00 |
| Jun 30, 2023 | 330,088.00 |
| Mar 31, 2023 | 229,107.00 |
| Dec 31, 2022 | -45,340.00 |
| Sep 30, 2022 | 199,110.00 |
| Jun 30, 2022 | -178,501.00 |
| Mar 31, 2022 | -78,101.00 |
| Dec 31, 2021 | -3,093.00 |
| Sep 30, 2021 | -774,631.00 |
| Jun 30, 2021 | 9.89 Mn |